Back to funds
View filing
Atle Fund Management AB
hedge fundUpdated 48 days agoManaged by Healthinvest Partners Ab • Latest filing Q2 2026
Portfolio value
$371.7M
Q2 2026
Filings
11
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
53.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 11 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2023 | $127.8M |
| Q1 2024 | $164.4M |
| Q2 2024 | $164M |
| Q3 2024 | $212.8M |
| Q4 2024 | $210.8M |
| Q1 2025 | $226.5M |
| Q2 2025 | $233.7M |
| Q3 2025 | $27M |
| Q4 2025 | $313.4M |
| Q1 2026 | $309.7M |
| Q2 2026 | $371.7M |
Top holdings
39 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LLY ELI LILLY & CO | $35.8M | 29.8K | 9.62% | Trimmed(-24.9%) |
| 2 | M MRK MERCK & CO. INC | $24.3M | 189.4K | 6.55% | Added(+459.4%) |
| 3 | J JNJ JOHNSON & JOHNSON | $21.7M | 85.4K | 5.84% | Trimmed(-7.5%) |
| 4 | A ABBV ABBVIE INC | $16.2M | 64.3K | 4.35% | Trimmed(-40.5%) |
| 5 | C CVS CVS HEALTH CORP | $15.1M | 146.1K | 4.07% | Added(+514.6%) |
| 6 | T TMO THERMO FISHER SCIENTIFIC CORP | $14M | 27.9K | 3.76% | Added(+21.2%) |
| 7 | ? N/A REVOLUTION MEDICINES INC | $13.7M | 73.1K | 3.68% | Trimmed(-88.2%) |
| 8 | B BIIB BIOGEN INC | $13.6M | 62.8K | 3.65% | — |
| 9 | N NBIX NEUROCRINE BIOSCIENCES INC | $12.3M | 72.9K | 3.31% | Trimmed(-18.7%) |
| 10 | M MIRM MIRUM PHARMACEUTICALS INC | $11.8M | 100.8K | 3.17% | Trimmed(-48.5%) |
| 11 | A ALKS ALKERMES PLC | $11.2M | 213.3K | 3.01% | Trimmed(-12.0%) |
| 12 | I IONS IONIS PHARMACEUTICALS INC | $10.9M | 137.1K | 2.93% | Added(+392.0%) |
| 13 | B BEIGF BEONE MEDICINES LTD-ADR | $10M | 35.2K | 2.70% | Trimmed(-15.7%) |
| 14 | I ISRG INTUITIVE SURGICAL INC | $9.8M | 24.7K | 2.64% | Trimmed(-65.2%) |
| 15 | S SYK STRYKER CORPORATION | $9.5M | 30.3K | 2.56% | Added(+12.8%) |
| 16 | V VRTX VERTEX PHARMACEUTICALS INC | $9.5M | 19.1K | 2.56% | Trimmed(-16.8%) |
| 17 | E EW EDWARDS LIFESCIENCES CORP | $9.3M | 103.2K | 2.51% | Trimmed(-3.1%) |
| 18 | B BBIO BRIDGEBIO PHARMA INC | $9.3M | 124.7K | 2.50% | Added(+12.0%) |
| 19 | K KRYS KRYSTAL BIOTECH, INC | $8.9M | 24.0K | 2.40% | Trimmed(-36.1%) |
| 20 | C COR CENCORA INC | $8.8M | 31.1K | 2.37% | Added(+32.6%) |